MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zelenaia, O.
Right arrow Articles by Robinson, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zelenaia, O.
Right arrow Articles by Robinson, M. B.

Vol. 57, Issue 4, 667-678, April 2000

Epidermal Growth Factor Receptor Agonists Increase Expression of Glutamate Transporter GLT-1 in Astrocytes through Pathways Dependent on Phosphatidylinositol 3-Kinase and Transcription Factor NF-kappa B

Olga Zelenaia,1 Brian D. Schlag,1 Gordon E. Gochenauer, Raquelli Ganel, Wei Song, Jacqueline S. Beesley, Judith B. Grinspan, Jeffrey D. Rothstein, and Michael B. Robinson

Departments of Pediatrics and Pharmacology (O.Z., B.D.S., G.E.G., M.B.R), Department of Neurology (J.B.G., J.S.B.), Department of Neuroscience (W.S.), Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania; and Department of Neurology, The Johns Hopkins University, Baltimore Maryland (R.G., J.D.R)

The glial glutamate transporter GLT-1 may be the predominant Na+-dependent glutamate transporter in forebrain. Expression of GLT-1 correlates with astrocyte maturation in vivo and increases during synaptogenesis. In astrocyte cultures, GLT-1 expression parallels differentiation induced by cAMP analogs or by coculturing with neurons. Molecule(s) secreted by neuronal cultures contribute to this induction of GLT-1, but little is known about the signaling pathways mediating this regulation. In the present study, we determined whether growth factors previously implicated in astrocyte differentiation regulate GLT-1 expression. Of the six growth factors tested, two [epidermal growth factor (EGF) and transforming growth factor-alpha ] induced expression of GLT-1 protein in cultured astrocytes. Induction of GLT-1 protein was accompanied by an increase in mRNA and in the Vmax for Na+-dependent glutamate transport activity. The effects of dibutyryl-cAMP and EGF were additive but were independently blocked by inhibitors of protein kinase A or protein tyrosine kinases, respectively. The induction of GLT-1 in both EGF- and dibutyryl-cAMP-treated astrocytes was blocked by inhibitors targeting phosphatidylinositol 3-kinase (PI3K) or the nuclear transcription factor-kappa B. Furthermore, transient transfection of astrocyte cultures with a constitutively active PI3K construct was sufficient to induce expression of GLT-1. These data suggest that independent but converging pathways mediate expression of GLT-1. Although an EGF receptor-specific antagonist did not block the effects of neuron-conditioned medium, the induction of GLT-1 by neuron-conditioned medium was completely abolished by inhibition of PI3K or nuclear factor-kappa B. EGF also increased expression of GLT-1 in spinal cord organotypic cultures. Together, these data suggest that activation of specific signaling pathways with EGF-like molecules may provide a novel approach for limiting excitotoxic brain injury.


1 O.Z. and B.D.S. contributed equally to the present study.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S.-G. Lee, Z.-Z. Su, L. Emdad, P. Gupta, D. Sarkar, A. Borjabad, D. J. Volsky, and P. B. Fisher
Mechanism of Ceftriaxone Induction of Excitatory Amino Acid Transporter-2 Expression and Glutamate Uptake in Primary Human Astrocytes
J. Biol. Chem., May 9, 2008; 283(19): 13116 - 13123.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Tian, L. Lai, H. Guo, Y. Lin, M. E. R. Butchbach, Y. Chang, and C.-l. G. Lin
Translational Control of Glial Glutamate Transporter EAAT2 Expression
J. Biol. Chem., January 19, 2007; 282(3): 1727 - 1737.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. G. Owe, P. Marcaggi, and D. Attwell
The ionic stoichiometry of the GLAST glutamate transporter in salamander retinal glia
J. Physiol., December 1, 2006; 577(2): 591 - 599.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zschocke, N. Bayatti, A. M. Clement, H. Witan, M. Figiel, J. Engele, and C. Behl
Differential Promotion of Glutamate Transporter Expression and Function by Glucocorticoids in Astrocytes from Various Brain Regions
J. Biol. Chem., October 14, 2005; 280(41): 34924 - 34932.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. Cavelier and D. Attwell
Tonic release of glutamate by a DIDS-sensitive mechanism in rat hippocampal slices
J. Physiol., April 15, 2005; 564(2): 397 - 410.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J.-C. Lievens, T. Rival, M. Iche, H. Chneiweiss, and S. Birman
Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila
Hum. Mol. Genet., March 1, 2005; 14(5): 713 - 724.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
A. H. Neufeld and B. Liu
Glaucomatous Optic Neuropathy: When Glia Misbehave
Neuroscientist, December 1, 2003; 9(6): 485 - 495.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
S. Han, H. Inoue, L. C. Flowers, and N. Sidell
Control of COX-2 Gene Expression through Peroxisome Proliferator-Activated Receptor {gamma} in Human Cervical Cancer Cells
Clin. Cancer Res., October 1, 2003; 9(12): 4627 - 4635.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Sung, G. Lim, and J. Mao
Altered Expression and Uptake Activity of Spinal Glutamate Transporters after Nerve Injury Contribute to the Pathogenesis of Neuropathic Pain in Rats
J. Neurosci., April 1, 2003; 23(7): 2899 - 2910.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z.-z. Su, M. Leszczyniecka, D.-c. Kang, D. Sarkar, W. Chao, D. J. Volsky, and P. B. Fisher
Insights into glutamate transport regulation in human astrocytes: Cloning of the promoter for excitatory amino acid transporter 2 (EAAT2)
PNAS, February 18, 2003; 100(4): 1955 - 1960.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. F. Behrens, P. Franz, B. Woodman, K. S. Lindenberg, and G. B. Landwehrmeyer
Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation
Brain, August 1, 2002; 125(8): 1908 - 1922.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. Suzuki, Y. Ikegaya, S. Matsuura, Y. Kanai, H. Endou, and N. Matsuki
Transient upregulation of the glial glutamate transporter GLAST in response to fibroblast growth factor, insulin-like growth factor and epidermal growth factor in cultured astrocytes
J. Cell Sci., March 12, 2002; 114(20): 3717 - 3725.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. D. Peavy, M. S. S. Chang, E. Sanders-Bush, and P. J. Conn
Metabotropic Glutamate Receptor 5-Induced Phosphorylation of Extracellular Signal-Regulated Kinase in Astrocytes Depends on Transactivation of the Epidermal Growth Factor Receptor
J. Neurosci., December 15, 2001; 21(24): 9619 - 9628.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. Mort, P. Marcaggi, J. Grant, and D. Attwell
Effect of Acute Exposure to Ammonia on Glutamate Transport in Glial Cells Isolated From the Salamander Retina
J Neurophysiol, August 1, 2001; 86(2): 836 - 844.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. K. Vorwerk, R. Naskar, F. Schuettauf, K. Quinto, D. Zurakowski, G. Gochenauer, M. B. Robinson, S. A. Mackler, and E. B. Dreyer
Depression of Retinal Glutamate Transporter Function Leads to Elevated Intravitreal Glutamate Levels and Ganglion Cell Death
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3615 - 3621.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics